Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

9431 ARTÍCULOS , VIENDO DEL 2371 AL 2385

Innovative Applications of MR-Guided Focused Ultrasound for Neurological Disorders

Stavarache MA, Chazen JL, Kaplitt MG.

World Neurosurg. 2021 Jan;145:581-589. doi: 10.1016/j.wneu.2020.08.052.

Significance of MRI Guided Focused Ultrasound Thalamotomy for Parkinson's Disease: A Review

Pooja NA, Pahuja SK, Veer K.

Curr Med Imaging. 2021;17(6):714-719. doi: 10.2174/1573405616666201223142505.

Magnetic resonance-guided focused ultrasound for Parkinson's disease since ExAblate, 2016-2019: a systematic review

Lennon JC, Hassan I.

Neurol Sci. 2021 Feb;42(2):553-563. doi: 10.1007/s10072-020-05020-1. Epub 2021 Jan 3.

Zonisamide effects on sleep problems and depressive symptoms in Parkinson's disease

Suzuki K, Fujita H, Matsubara T, Haruyama Y, Kadowaki T, Funakoshi K, Watanabe Y, Hirata K.

Brain Behav. 2021 Mar;11(3):e02026. doi: 10.1002/brb3.2026. Epub 2021 Jan 5.

Age-related vulnerability to nigral dopaminergic degeneration in rats via Zn(2+)-permeable GluR2-lacking AMPA receptor activation

Nakajima S, Saeki N, Tamano H, Nishio R, Katahira M, Takeuchi A, Takeda A.

Neurotoxicology. 2021 Mar;83:69-76. doi: 10.1016/j.neuro.2020.12.014. Epub 2021 Jan 2.

Brain Motor Network Changes in Parkinson's Disease: Evidence from Meta-Analytic Modeling

Herz DM, Meder D, Camilleri JA, Eickhoff SB, Siebner HR.

Mov Disord. 2021 May;36(5):1180-1190. doi: 10.1002/mds.28468. Epub 2021 Jan 11.

Molecular Imaging of Extrapyramidal Movement Disorders With Dementia: The 4R Tauopathies

Frey KA.

Semin Nucl Med. 2021 May;51(3):275-285. doi: 10.1053/j.semnuclmed.2020.12.003. Epub 2021 Jan 8.

A Double-Blind, Randomized, Controlled Trial of Lovastatin in Early-Stage Parkinson's Disease

Lin CH, Chang CH, Tai CH, Cheng MF, Chen YC, Chao YT, Huang TL, Yen RF, Wu RM.

Mov Disord. 2021 May;36(5):1229-1237. doi: 10.1002/mds.28474. Epub 2021 Jan 15.

A Report of Tamoxifen and Parkinson's Disease in a US Population and a Review of the Literature

Avram CM, Brumbach BH, Hiller AL.

Mov Disord. 2021 May;36(5):1238-1242. doi: 10.1002/mds.28471. Epub 2021 Jan 15.

Hyperhomocysteinemia and Dementia Associated With Severe Cortical Atrophy, but No Amyloid Burden

Reffo A, Gabelli C.

J Geriatr Psychiatry Neurol. 2022 Jan;35(1):57-61. doi: 10.1177/0891988720988910. Epub 2021 Jan 19.

The effectiveness of specialized nursing interventions for patients with Parkinson disease: A randomized controlled study protocol

Chen Y, Lu T, Jiang X, Huang X.

Medicine (Baltimore). 2021 Jan 15;100(2):e23972. doi: 10.1097/MD.0000000000023972.

Neuroprotective potential of cinnamon and its metabolites in Parkinson's disease: Mechanistic insights, limitations, and novel therapeutic opportunities

Angelopoulou E, Paudel YN, Piperi C, Mishra A.

J Biochem Mol Toxicol. 2021 Apr;35(4):e22720. doi: 10.1002/jbt.22720. Epub 2021 Jan 24.

Higher Concentration of Plasma Glial Fibrillary Acidic Protein in Wilson Disease Patients with Neurological Manifestations

Lin J, Zheng Y, Liu Y, Lin Y, Wang Q, Lin XH, Zhu W, Lin WH, Wang N, Chen WJ, Fu Y.

Mov Disord. 2021 Jun;36(6):1446-1450. doi: 10.1002/mds.28509. Epub 2021 Jan 27.

Concomitant improvement in anti-saccade success rate and postural instability gait difficulty after rTMS treatment for Parkinson's disease

Okada KI, Takahira M, Mano T, Uga T, Konaka K, Hosomi K, Saitoh Y.

Sci Rep. 2021 Jan 28;11(1):2472. doi: 10.1038/s41598-021-81795-3.

Nuclear Genes Associated with Mitochondrial DNA Processes as Contributors to Parkinson's Disease Risk

Müller-Nedebock AC, van der Westhuizen FH, Kõks S, Bardien S.

Mov Disord. 2021 Apr;36(4):815-831. doi: 10.1002/mds.28475. Epub 2021 Jan 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias